(₹ crores) | Q1FY26 | Q4FY25 | Q1FY25 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 432.12 | 407.46 | 397.72 | 6.1% | 8.6% |
Total Expenses | 437.27 | 451.17 | 421.20 | -3.1% | 3.8% |
Profit Before Tax | -5.15 | -93.51 | -23.48 | -94.5% | -78.1% |
Tax | -0.01 | -11.72 | 11.17 | -99.9% | -100.1% |
Profit After Tax | -10.68 | -81.79 | -34.65 | -86.9% | -69.2% |
Earnings Per Share | -0.50 | -4.60 | -2.00 | -89.1% | -75.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Camlin Fine Sciences Ltd is a company involved in the production and distribution of specialty chemicals. The company primarily operates in the aroma chemicals sector, providing products such as antioxidants, performance chemicals, and aroma ingredients. These products find applications in a variety of industries, including food and beverage, pet food, animal and aqua nutrition, and pharmaceuticals. Recently, Camlin Fine Sciences has been focusing on expanding its global footprint and enhancing its production capacities to meet increasing demand. However, specific recent developments regarding strategic initiatives or partnerships are not available in the provided data.
In the first quarter of fiscal year 2026 (Q1FY26), Camlin Fine Sciences Ltd reported a total income of ₹432.12 crores. This marks a quarter-over-quarter (QoQ) increase of 6.1% from ₹407.46 crores recorded in the fourth quarter of fiscal year 2025 (Q4FY25). Year-over-year (YoY), total income rose by 8.6% from ₹397.72 crores in the first quarter of fiscal year 2025 (Q1FY25). The consistent increase in revenue reflects a positive revenue trajectory over both the quarterly and annual periods.
The company's profitability metrics show improvement over the recent quarters. The Profit Before Tax (PBT) for Q1FY26 was reported at a negative ₹5.15 crores, which is a significant reduction in losses compared to a negative ₹93.51 crores in Q4FY25, reflecting a 94.5% QoQ improvement. Year-over-year, the PBT improved by 78.1% from a negative ₹23.48 crores in Q1FY25. Similarly, the Profit After Tax (PAT) for Q1FY26 was a negative ₹10.68 crores, indicating a substantial improvement from the negative ₹81.79 crores in Q4FY25 and a 69.2% YoY improvement from a negative ₹34.65 crores in Q1FY25. These metrics suggest a significant decrease in losses over the respective periods.
Operational efficiency is further highlighted through the total expenses, which decreased by 3.1% QoQ from ₹451.17 crores in Q4FY25 to ₹437.27 crores in Q1FY26. However, there is a 3.8% YoY increase from ₹421.20 crores in Q1FY25. Earnings Per Share (EPS) also improved, with a negative ₹0.50 in Q1FY26 compared to a negative ₹4.60 in Q4FY25, showing an 89.1% QoQ improvement. Year-over-year, EPS improved by 75.0% from a negative ₹2.00 in Q1FY25. The tax expenses also saw a dramatic reduction, with Q1FY26 reflecting a negligible negative ₹0.01 crores compared to negative ₹11.72 crores in Q4FY25 and a positive ₹11.17 crores in Q1FY25. These operating metrics indicate improvements in the company’s operational management over the reporting periods.
Camlin Fine Sciences Ltd announced its Q1 FY 2025-26 results on 9 August, 2025.
Camlin Fine Sciences Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Camlin Fine Sciences Ltd Q1 FY 2025-26 results include:
Camlin Fine Sciences Ltd reported a net loss of ₹-10.68 crore in Q1 FY 2025-26, reflecting a -69.2% year-over-year growth.
Camlin Fine Sciences Ltd posted a revenue of ₹432.12 crore in Q1 FY 2025-26.